42 49

Cited 0 times in

Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B

Authors
 Eun Hye Kim  ;  Hana Park  ;  Kun Ho Lee  ;  Sang Hoon Ahn  ;  Seung-Min Kim  ;  Kwang-Hyub Han 
Citation
 CLINICAL AND MOLECULAR HEPATOLOGY, Vol.19(1) : 82-86, 2013-03 
Journal Title
 CLINICAL AND MOLECULAR HEPATOLOGY 
ISSN
 2287-2728 
Issue Date
2013-03
Keywords
Adverse effects ; Hepatitis B ; Myopathy ; Telbivudine
Abstract
Telbivudine is an L-nucleoside analogue with potent antiviral activity against hepatitis B virus (HBV). Clinical trials have shown that telbivudine has a more potent and sustained antiviral activity with a lower frequency of viral resistance than lamivudine. Although there are several reports concerning the safety profile of telbivudine, most adverse events are described as mild and transient in nature. Here we report two cases of telbivudine-induced myopathy in patients with chronic hepatitis B who were siblings.
Files in This Item:
T201306406.pdf Download
DOI
10.3350/cmh.2013.19.1.82
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Ahn, Sang Hoon(안상훈) ORCID logo https://orcid.org/0000-0002-3629-4624
Han, Kwang-Hyub(한광협) ORCID logo https://orcid.org/0000-0003-3960-6539
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/178451
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links